A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers

NCT05248841 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DRUG: HEC-Glargine
DRUG: US-Lantus

Sponsor

Lannett Company, Inc.

Collaborators

[object Object]
[object Object]